# Effect of Intralesional Injection of Corticosteroids Combined with Hyaluronidase in Treatment of Minimal Associated Pathological Lesions of Vocal Folds, Participants and Condition: Patients with Benign Vocal Fold Lesions, Intervention: Intralesional Injection Via Working Channel of Nasofiberscope

> **NCT06854380** · EARLY_PHASE1 · RECRUITING · sponsor: **Mansoura University** · enrollment: 20 (estimated)

## Conditions studied

- Voice and Voice Disorders

## Interventions

- **DRUG:** Intralesional injection of steroids (betamethasone), (Betafos®) and hyaluronidase (enzyme), (Hynidase®) into benign vocal fold lesions by a naso-fiberscope with a side working channel(Storz 11001UD1)

## Key facts

- **NCT ID:** NCT06854380
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06854380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06854380, "Effect of Intralesional Injection of Corticosteroids Combined with Hyaluronidase in Treatment of Minimal Associated Pathological Lesions of Vocal Folds, Participants and Condition: Patients with Benign Vocal Fold Lesions, Intervention: Intralesional Injection Via Working Channel of Nasofiberscope". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06854380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*